Johanna Mercier, Chief Communications & Corporate Affairs Officer at Gilead Sciences, sold 27,900 shares of common stock on May 15, 2026, for a total value of approximately $3,676,198.
The sales occurred at prices ranging from $129.66 to $132.78 per share. On the same day, Mercier acquired 25,000 shares at a price of $66.64 per share through the exercise of stock options.
All transactions were executed under a Rule 10b5-1 trading plan adopted on February 20, 2025.
Following the transactions, Mercier directly holds 125,779 shares and has 23,110 unexercised options.
Bond.az notes that Gilead has raised its dividend for 11 consecutive years, currently yielding 2.5%.
